648581- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient darifenacin (ATC code: G04BD10).

World Biggest Tenders Source

This tender with title 648581- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient darifenacin (ATC code: G04BD10). has been published on Bidding Source portal dated 05 Oct 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

648581- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient darifenacin (ATC code: G04BD10).

Tender Type :

Invitation for Bids

Reference No. :

648581

Country :

Germany

Publish Date :

5 Oct 2025

Closing Date :

27 Sep 2027

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

647890- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient peginterferon alfa-2a (ATC Code: L03AB11). Germany 641838- Germany – Pharmaceutical products – Open framework agreement on pharmaceutical discounts pursuant to Section 130a Paragraph 8 of the Social Code Book V with the option to join at any time, so-called approval model 2025-01 Germany 640361- Germany – Pharmaceutical products – Open framework agreement on pharmaceutical discounts pursuant to Section 130a Paragraph 8 SGB V with the option to join at any time, so-called approval model 2024-09 Germany 645643- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2024-03 - Omalizumab Germany 640041- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 or 130c Paragraph 1 SGB V for the period from 1 November 2025 to 31 October 2027 Germany 643632-Awarded - Germany – Pharmaceutical products – Open House discount agreements of TK - Announcements of the conclusion of contracts with contract start date on 01.09.2025 Germany 642826-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V between IKK classic and Abacus Medicine A/S for Zutectra(R). Germany 640627-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Sections 130a (8), 130c (1) V SGB V between IKK classic and Thea Pharma GmbH for Vevizye(R) Germany 640433-Awarded - Germany – Pharmaceutical products – 1/DLII6/PM030 diverse Arzneimittel -- <b>Contract Value: 538 742,40 EUR</b> Germany 650289- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130 a Paragraph 8 SGB V from 1 November 2025 Germany

648581- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient darifenacin (ATC code: G04BD10).

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com